BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21133620)

  • 21. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
    Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
    J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to identification of HNPCC suspected patients in Slovak population.
    Fridrichová I; Ilencíková D; Friedl W; Hlavcák P; Skorvaga M; Krizan P; Pálaj J; Pirsel M; Farkasová E; Bartosová Z
    Neoplasma; 2000; 47(4):219-26. PubMed ID: 11043825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CAT25 is a mononucleotide marker to identify HNPCC patients.
    Bianchi F; Galizia E; Catalani R; Belvederesi L; Ferretti C; Corradini F; Cellerino R
    J Mol Diagn; 2009 May; 11(3):248-52. PubMed ID: 19324995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer.
    Findeisen P; Kloor M; Merx S; Sutter C; Woerner SM; Dostmann N; Benner A; Dondog B; Pawlita M; Dippold W; Wagner R; Gebert J; von Knebel Doeberitz M
    Cancer Res; 2005 Sep; 65(18):8072-8. PubMed ID: 16166278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.
    Vilar E; Mork ME; Cuddy A; Borras E; Bannon SA; Taggart MW; Ying J; Broaddus RR; Luthra R; Rodriguez-Bigas MA; Lynch PM; You YQ
    Cancer Genet; 2014; 207(10-12):495-502. PubMed ID: 25432668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microsatellite instability testing in Korean patients with colorectal cancer.
    Oh JR; Kim DW; Lee HS; Lee HE; Lee SM; Jang JH; Kang SB; Ku JL; Jeong SY; Park JG
    Fam Cancer; 2012 Sep; 11(3):459-66. PubMed ID: 22669410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Microsatellite analysis and hMLH1/hMSH2 expression detection in young patients with colorectal cancer: value in screening hereditary nonpolyposis colorectal cancer].
    Yang L; Ding YQ; Li GX; Yu J; Wang Y; Zhou J; Yang HJ; Zhang JH
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):779-82. PubMed ID: 17584637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic testing for hereditary nonpolyposis colorectal cancer.
    Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
    Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
    Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
    J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer.
    Buhard O; Lagrange A; Guilloux A; Colas C; Chouchène M; Wanherdrick K; Coulet F; Guillerm E; Dorard C; Marisa L; Bokhari A; Greene M; El-Murr N; Bodo S; Muleris M; Sourouille I; Svrcek M; Cervera P; Blanché H; Lefevre JH; Parc Y; Lepage C; Chapusot C; Bouvier AM; Gaub MP; Selves J; Garrett K; Iacopetta B; Soong R; Hamelin R; Garrido C; Lascols O; André T; Fléjou JF; Collura A; Duval A
    J Med Genet; 2016 Jun; 53(6):377-84. PubMed ID: 26831756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Vasen HF
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():113-26. PubMed ID: 18081655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of the mononucleotide marker "BAT-26" for identification of microsatellite instability in colorectal cancers.
    Watanabe T; Matsuda K; Ishihara S; Nozawa K; Hayama T; Yamada H; Iinuma H
    Asian Pac J Cancer Prev; 2011; 12(1):335. PubMed ID: 21517282
    [No Abstract]   [Full Text] [Related]  

  • 33. Population-based molecular detection of hereditary nonpolyposis colorectal cancer.
    Salovaara R; Loukola A; Kristo P; Kääriäinen H; Ahtola H; Eskelinen M; Härkönen N; Julkunen R; Kangas E; Ojala S; Tulikoura J; Valkamo E; Järvinen H; Mecklin JP; Aaltonen LA; de la Chapelle A
    J Clin Oncol; 2000 Jun; 18(11):2193-200. PubMed ID: 10829038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mononucleotide repeats BAT-26 and BAT-25 accurately detect MSI-H tumors and predict tumor content: implications for population screening.
    Brennetot C; Buhard O; Jourdan F; Flejou JF; Duval A; Hamelin R
    Int J Cancer; 2005 Jan; 113(3):446-50. PubMed ID: 15455342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microsatellite instability testing in colorectal carcinoma: a practical guide.
    Gibson J; Lacy J; Matloff E; Robert M
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):171-6.e1. PubMed ID: 24434275
    [No Abstract]   [Full Text] [Related]  

  • 37. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of MT1XT20 Single Quasi-Monomorphic Mononucleotide Marker for Characterizing Microsatellite Instability in Persian Lynch Syndrome Patients.
    Farahani N; Nikpou P; Emami MH; Hashemzadeh M; Zeinalian M; Shariatpanahi SS; Salehi R
    Asian Pac J Cancer Prev; 2016; 17(9):4259-4265. PubMed ID: 27797228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of DNA mismatch repair-deficient colorectal cancer.
    Stadler ZK
    Hematol Oncol Clin North Am; 2015 Feb; 29(1):29-41. PubMed ID: 25475571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular screening of potential HNPCC patients using a multiplex microsatellite PCR system.
    Sutter C; Gebert J; Bischoff P; Herfarth C; von Knebel Doeberitz M
    Mol Cell Probes; 1999 Apr; 13(2):157-65. PubMed ID: 10208807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.